These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11759311)

  • 1. New screening procedure signals risk of CVD at earlier stage.
    Dis Manag Advis; 2001 Nov; 7(11):166-9, 161. PubMed ID: 11759311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G; Kerr A
    N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the health care system can influence cardiovascular disease risk factors.
    Smith SC
    Prev Med; 1999 Dec; 29(6 Pt 2):S66-71. PubMed ID: 10641820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender disparities in the quality of cardiovascular disease care in private managed care plans.
    Chou AF; Scholle SH; Weisman CS; Bierman AS; Correa-de-Araujo R; Mosca L
    Womens Health Issues; 2007; 17(3):120-30. PubMed ID: 17448685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the prevention and treatment of cardiovascular disease.
    Weisfeldt ML; Zieman SJ
    Health Aff (Millwood); 2007; 26(1):25-37. PubMed ID: 17211011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L; Wells S; Broad J; Riddell T; Jackson R
    N Z Med J; 2006 Nov; 119(1245):U2313. PubMed ID: 17146488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases.
    Safar ME; Levy BI; Struijker-Boudier H
    Circulation; 2003 Jun; 107(22):2864-9. PubMed ID: 12796414
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular risk assessment in prediabetes: A hypothesis.
    Nwose EU; Richards RS; Cann NG; Butkowski E
    Med Hypotheses; 2009 Mar; 72(3):271-5. PubMed ID: 19042094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of individual cardiovascular risk in a primary prevention setting shows a high number of patients with a high risk score.
    Neuss M; Roser M; Kelle S; Girke F; Winbeck G; Stawowy P; Fleck E
    Z Kardiol; 2004 May; 93(5):413-5. PubMed ID: 15160278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New indications for the prevention of cardiovascular diseases].
    Tenconi MT;
    Ann Ig; 2008; 20(3 Suppl 1):53-7. PubMed ID: 18773606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and management of the workplace for CVD risk.
    Nowack KM; Schnall P; Melamed S; Froom P; Fisher J; Belkić K
    Occup Med; 2000; 15(1):231-56. PubMed ID: 10702088
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
    Shah M; Butler M; Bramley T; Curtice TG; Fine S
    Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.
    Valdez R; Greenlund KJ; Khoury MJ; Yoon PW
    Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I; Hamilton G; Humphrey A; Scragg A
    N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening dentists for risk factors associated with cardiovascular disease.
    Simmons MS; Little JW; Rhodus NL; Verrusio AC; Kunik RL; Merry JW
    Gen Dent; 1994; 42(5):440-5. PubMed ID: 7489877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.